Skip to main content

ADVERTISEMENT

Abstracts

Purpose: Primary liver cancer is the sixth most diagnosed cancer and Hepatocellular carcinoma (HCC) accounts for 75-95% of all primary liver cancer cases1. Several studies have been perfo...
11/01/2023
Purpose: This study aimed to evaluate socioeconomic and demographic factors that predict overall survival (OS) and progression free survival (PFS) of patients undergoing transarterial che...
11/01/2023
Purpose: To demonstrate proof of concept for CT based tumor dosimetry after treatment of Hepatocellular Carcinoma (HCC) with multimodal imageable yttrium-90 (90Y) microspheres (Eye90 micr...
11/01/2023
Faisal Al-Qawasmi
CIO2023 Highlights
11/01/2023
Faisal Al-Qawasmi discusses his CIO2023 abstract, "CIO 2023-3 Enhancing Treatment of Hepatocellular Carcinoma With Cowpea Mosaic Virus as an Adjuvant Therapy."
Faisal Al-Qawasmi discusses his CIO2023 abstract, "CIO 2023-3 Enhancing Treatment of Hepatocellular Carcinoma With Cowpea Mosaic Virus as an Adjuvant Therapy."
Faisal Al-Qawasmi discusses his...
11/01/2023
IO Learning
The Impact of Anticoagulation in Patients With Moderate Risk CHA2DS2-VASc
Purpose: Current guidelines recommend the use of anticoagulation for atrial fibrillation (AF) patients with ≥2 non-gender risk factors according to the CHA2DS2-VASc stroke risk score. How...
07/19/2023
07/19/2023
Periodontal Disease and Risk of Atrial Fibrillation and Atrial flutter: A Meta-Analysis
07/19/2023